Expensify (EXFY) Competitors $3.07 +0.30 (+10.83%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends EXFY vs. DH, BMBL, TUYA, PUBM, SCWX, HUYA, EVER, OSPN, ECX, and RXTShould you be buying Expensify stock or one of its competitors? The main competitors of Expensify include Definitive Healthcare (DH), Bumble (BMBL), Tuya (TUYA), PubMatic (PUBM), SecureWorks (SCWX), HUYA (HUYA), EverQuote (EVER), OneSpan (OSPN), ECARX (ECX), and Rackspace Technology (RXT). These companies are all part of the "computer software" industry. Expensify vs. Definitive Healthcare Bumble Tuya PubMatic SecureWorks HUYA EverQuote OneSpan ECARX Rackspace Technology Expensify (NASDAQ:EXFY) and Definitive Healthcare (NASDAQ:DH) are both small-cap business services companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, institutional ownership, profitability, earnings, dividends, risk, valuation and media sentiment. Does the media refer more to EXFY or DH? In the previous week, Expensify had 5 more articles in the media than Definitive Healthcare. MarketBeat recorded 6 mentions for Expensify and 1 mentions for Definitive Healthcare. Definitive Healthcare's average media sentiment score of 0.00 beat Expensify's score of -0.48 indicating that Definitive Healthcare is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Expensify 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Definitive Healthcare 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings & valuation, EXFY or DH? Expensify has higher earnings, but lower revenue than Definitive Healthcare. Expensify is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioExpensify$137.44M1.72-$41.46M-$0.18-17.06Definitive Healthcare$255.85M1.85-$202.39M-$3.10-1.32 Is EXFY or DH more profitable? Expensify has a net margin of -11.81% compared to Definitive Healthcare's net margin of -142.38%. Definitive Healthcare's return on equity of 1.76% beat Expensify's return on equity.Company Net Margins Return on Equity Return on Assets Expensify-11.81% -14.72% -8.89% Definitive Healthcare -142.38%1.76%1.12% Which has more risk and volatility, EXFY or DH? Expensify has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.33, indicating that its stock price is 33% more volatile than the S&P 500. Do analysts prefer EXFY or DH? Expensify presently has a consensus target price of $2.83, suggesting a potential downside of 7.71%. Definitive Healthcare has a consensus target price of $5.81, suggesting a potential upside of 41.77%. Given Definitive Healthcare's higher probable upside, analysts plainly believe Definitive Healthcare is more favorable than Expensify.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Expensify 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50Definitive Healthcare 1 Sell rating(s) 7 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.18 Do institutionals & insiders hold more shares of EXFY or DH? 68.4% of Expensify shares are owned by institutional investors. Comparatively, 98.7% of Definitive Healthcare shares are owned by institutional investors. 17.3% of Expensify shares are owned by company insiders. Comparatively, 14.8% of Definitive Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Does the MarketBeat Community favor EXFY or DH? Definitive Healthcare received 7 more outperform votes than Expensify when rated by MarketBeat users. However, 30.36% of users gave Expensify an outperform vote while only 28.92% of users gave Definitive Healthcare an outperform vote. CompanyUnderperformOutperformExpensifyOutperform Votes1730.36% Underperform Votes3969.64% Definitive HealthcareOutperform Votes2428.92% Underperform Votes5971.08% SummaryDefinitive Healthcare beats Expensify on 10 of the 18 factors compared between the two stocks. Ad Crypto 101 MediaBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…YES, I WANT THE #1 CRYPTO NOW Get Expensify News Delivered to You Automatically Sign up to receive the latest news and ratings for EXFY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EXFY vs. The Competition Export to ExcelMetricExpensifyPrepackaged software IndustryBusiness SectorNASDAQ ExchangeMarket Cap$236.87M$25.00B$6.94B$8.82BDividend YieldN/A2.33%2.92%4.07%P/E Ratio-17.0593.2046.3217.81Price / Sales1.728.05205.2374.57Price / CashN/A87.3924.4032.53Price / Book2.1011.015.094.68Net Income-$41.46M$444.73M$121.42M$226.08M7 Day Performance7.34%-0.07%0.18%-1.04%1 Month Performance73.94%4.17%8.46%1.04%1 Year Performance30.64%23.90%30.83%26.28% Expensify Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EXFYExpensify0.8201 of 5 stars$3.07+10.8%$2.83-7.7%+23.3%$213.72M$150.69M-17.05133Insider TradeGap UpDHDefinitive Healthcare1.7209 of 5 stars$4.10-1.9%$5.81+41.8%-50.3%$473.64M$255.85M-1.34970BMBLBumble1.6189 of 5 stars$7.75-0.9%$8.38+8.1%-46.7%$838.41M$1.08B-1.581,200TUYATuya2.3741 of 5 stars$1.57-1.3%$2.70+72.0%-12.3%$801.98M$229.99M0.001,465PUBMPubMatic4.0789 of 5 stars$15.25-1.5%$21.71+42.4%-5.9%$768.06M$267.01M49.19880News CoverageSCWXSecureWorks0.7678 of 5 stars$8.37+0.1%$7.00-16.4%+40.4%$742.60M$365.88M0.001,516HUYAHUYA2.925 of 5 stars$3.05-1.3%$5.68+86.1%-21.4%$720.23M$985.13M0.001,345EVEREverQuote4.6793 of 5 stars$18.85+0.3%$28.50+51.2%+120.7%$664.25M$287.92M55.44610Analyst RevisionPositive NewsOSPNOneSpan4.0691 of 5 stars$17.26+1.8%$17.13-0.8%+70.0%$644.33M$235.11M23.32526ECXECARX0.2915 of 5 stars$1.64+10.8%N/A-46.4%$554.24M$5.46B-3.282,020Gap UpRXTRackspace Technology0.5596 of 5 stars$2.32-2.1%$2.47+6.3%+58.9%$539.34M$2.96B0.005,800Analyst Forecast Related Companies and Tools Related Companies Definitive Healthcare Competitors Bumble Competitors Tuya Competitors PubMatic Competitors SecureWorks Competitors HUYA Competitors EverQuote Competitors OneSpan Competitors ECARX Competitors Rackspace Technology Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:EXFY) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Expensify, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Expensify With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
